Supernus Pharmaceuticals Inc (SUPN)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 73,865 | 1,316 | 60,711 | 53,424 | 126,950 |
| Total assets | US$ in thousands | 1,368,070 | 1,277,670 | 1,702,510 | 1,689,150 | 1,504,100 |
| ROA | 5.40% | 0.10% | 3.57% | 3.16% | 8.44% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $73,865K ÷ $1,368,070K
= 5.40%
Supernus Pharmaceuticals Inc's return on assets (ROA) has exhibited fluctuations over the past five years. The ROA decreased from 8.44% as of December 31, 2020, to 3.16% as of December 31, 2021. There was a slight increase to 3.57% by December 31, 2022, followed by a significant decline to 0.10% by December 31, 2023. However, the ROA improved to 5.40% by December 31, 2024.
The declining trend in ROA from 2020 to 2023 may raise concerns about the company's ability to generate profits relative to its asset base during those years. The subsequent increase in ROA by the end of 2024 signifies a potential improvement in efficiency in generating earnings from its assets.
Further analysis of the company's financial performance, asset utilization, and profitability drivers is recommended to better understand the factors influencing Supernus Pharmaceuticals Inc's ROA fluctuations over the period.
Peer comparison
Dec 31, 2024